Israeli scientists offer new hope for Gaucher patients Weizmann Institute of Science researchers have discovered a new cellular pathway implicated in Gaucher disease.
FDA approves Israeli-made Gaucher drug Elelyso A new Israeli developed treatment for Gaucher disease is set to hit pharmacies around the globe, following approval of the new drug by the American